expert roundtables

Predicting Treatment Response in Patients With Inadequate Responses to Methotrexate
Rheumatology

Predicting Treatment Response in Patients With Inadequate Responses to Methotrexate

expert roundtables
By Jeffrey R. Curtis, MD, MS, MPH; Jonathan Kay, MD; Leonard H. Calabrese, DO
Changing the Natural History of Sickle Cell Disease
Hematology

Changing the Natural History of Sickle Cell Disease

expert roundtables
By Julie Kanter, MD; Michael Rutledge DeBaun, MD, MPH; Stella T. Chou, MD
The Evolving Treatment Landscape for Sickle Cell Disease
Hematology

The Evolving Treatment Landscape for Sickle Cell Disease

expert roundtables
By Julie Kanter, MD; Michael Rutledge DeBaun, MD, MPH; Stella T. Chou, MD
Monitoring for the Transition From Nonmetastatic Castration-Resistant Prostate Cancer to Detectable Metastatic Disease
Oncology

Monitoring for the Transition From Nonmetastatic Castration-Resistant Prostate Cancer to Detectable Metastatic Disease

expert roundtables
By Daniel P. Petrylak, MD; Leonard Gomella, MD
Defining Nonmetastatic Castration-Resistant Prostate Cancer and Weighing the Options for Treatment
Oncology

Defining Nonmetastatic Castration-Resistant Prostate Cancer and Weighing the Options for Treatment

expert roundtables
By Daniel P. Petrylak, MD; Leonard Gomella, MD
Load More